Evidence map›Paper›PMID 22926851›Full record

ArticleAnnals of neurology2012

Familial cortical myoclonus with a mutation in NOL3.

Jonathan F Russell, Jamie L Steckley, Giovanni Coppola, Angelika F G Hahn, MacKenzie A Howard, Zachary Kornberg, Alden Huang, Seyed M Mirsattari, Barry Merriman, Eric Klein and 10 more

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 2 countries.

Jonathan F RussellDepartment of Neurology, School of Medicine, University of California at San Francisco, San Francisco, CA 94158, USA.
Jamie L Steckley
Giovanni Coppola
Angelika F G Hahn
MacKenzie A Howard
Zachary Kornberg
Alden Huang
Seyed M Mirsattari
Barry Merriman
Eric Klein
Murim Choi
Hsien-Yang Lee
Andrew Kirk
Carol Nelson-Williams
Gillian Gibson
Scott C Baraban
Richard P Lifton
Daniel H Geschwind
Ying-Hui Fu
Louis J Ptáček
Howard Hughes Medical Institute · USUniversity of California, Los Angeles · USUniversity of California, San Francisco · USNeurological Surgery · USWestern University · CALondon Health Sciences Centre · CARoyal University Hospital · CAUniversity of British Columbia · CA

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
The molecular and genetic basis of myoclonic epilepsyR01NS044379 · NINDS · UNIVERSITY OF UTAH · PI PTACEK, LOUIS J. · 2002 to 2006
$1.8M
Molecular Pathophysiology of Familial Cortical MyoclonusF31NS077533 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUSSELL, JONATHAN FOSTER · 2011 to 2013
$54k
Howard Hughes Medical InstituteNCRR NIH HHS U54 RR19481NIGMS NIH HHS T32 GM007618NIGMS NIH HHS T32GM07618NINDS NIH HHS F31 NS077533NINDS NIH HHS F31NS077533NINDS NIH HHS NS044379NINDS NIH HHS R01 NS044379
6 · The paper itself

Abstract

objectiveMyoclonus is characterized by sudden, brief involuntary movements, and its presence is debilitating. We identified a family suffering from adult onset, cortical myoclonus without associated seizures. We performed clinical, electrophysiological, and genetic studies to define this phenotype.

methodsA large, 4-generation family with a history of myoclonus underwent careful questioning, examination, and electrophysiological testing. Thirty-five family members donated blood samples for genetic analysis, which included single nucleotide polymorphism mapping, microsatellite linkage, targeted massively parallel sequencing, and Sanger sequencing. In silico and in vitro experiments were performed to investigate functional significance of the mutation.

resultsWe identified 11 members of a Canadian Mennonite family suffering from adult onset, slowly progressive, disabling, multifocal myoclonus. Somatosensory evoked potentials indicated a cortical origin of the myoclonus. There were no associated seizures. Some severely affected individuals developed signs of progressive cerebellar ataxia of variable severity late in the course of their illness. The phenotype was inherited in an autosomal dominant fashion. We demonstrated linkage to chromosome 16q21-22.1. We then sequenced all coding sequence in the critical region, identifying only a single cosegregating, novel, nonsynonymous mutation, which resides in the gene NOL3. Furthermore, this mutation was found to alter post-translational modification of NOL3 protein in vitro.

interpretationWe propose that familial cortical myoclonus is a novel movement disorder that may be caused by mutation in NOL3. Further investigation of the role of NOL3 in neuronal physiology may shed light on neuronal membrane hyperexcitability and pathophysiology of myoclonus and related disorders.

Indexed as

Family HealthAdolescentAdultAge of OnsetAnimalsApoptosis Regulatory ProteinsCanadaCell Line, TransformedChromosome MappingChromosomes, Human, Pair 16ElectroencephalographyFemaleGenetic Predisposition to DiseaseGlutamic AcidHumansMaleApoptosis Regulatory ProteinsGlutamic AcidMuscle ProteinsNOL3 protein, humanProline

Identifiers

PMID22926851
PMCPMC3431191
OpenAlexW1971129496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.